Cannabinoid Encyclopedia

Cannabinoid guide

What is Delta-10 THC?

A clear guide to Delta-10 THC: what it is, what researchers have studied, how strong the evidence is, and what to know about safety.

Updated July 2026 12 research sources Human research included

The short answer

Delta-10 THC, in simple terms

Delta-10 THC is a cannabinoid-related compound represented in the scientific literature. Researchers study it for possible effects, safety, and how it works in the body. The source set includes human research as well as earlier-stage studies. The evidence does not turn this into one proven benefit, because studies can use different products, doses, routes, people, and outcomes. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about Delta-10 THC.

Why people look into itSee the main questions before the research details. What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Why people look into Delta-10 THC

What Delta-10 THC is commonly talked about for

These cards show the questions most represented in this source set. They are not a list of proven benefits, and the evidence label matters as much as the topic name.

  1. Human and early-stage research

    Safety, risk, adverse events, and formulation concerns

    Safety research asks how Delta-10 THC, its dose, route, formulation, and other medications may change risk. The available evidence may not answer the safety question for every product or person. 2

    See research areas

Bottom line: Start with the exact question you care about, then check the study type, product, dose, and outcome before treating a research signal as a real-world effect.

Key takeaways

What to know first

  1. 1

    Research on Delta-10 THC covers Safety, risk, adverse events, and formulation concerns; those areas should not be combined into one claim. 1

  2. 2

    The source set includes human research as well as earlier-stage studies. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What has Delta-10 THC been studied for?

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Human and early-stage research

Safety, risk, adverse events, and formulation concerns

Researchers have examined Delta-10 THC in connection with Safety, risk, adverse events, and formulation concerns. The studies may differ in compound, formulation, dose, route, population, and outcome. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

5 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

1 source

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

1 source

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 5 of 12 research sources could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on Delta-10 THC is not one kind of study. This source set includes 3 case report or case seriess, 2 animal studies, and 1 narrative or expert review. 3

The recorded populations or models include people or patients (4 sources), animal models (1 source), and pediatric, adolescent, or developmental context (1 source). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is safety, risk, adverse-event, or formulation-specific concerns (12 sources). Closely related outcome names can still describe different measurements. 5

The Delta-10 THC source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

evidence still limited

Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America's Poison Centers.

On this page, this source examines Delta-8 THC and safety, risk, adverse-event, or formulation-specific concerns. 1

Population or model
pediatric, adolescent, or developmental context
Outcome focus
safety, risk, adverse-event, or formulation-specific concerns
Evidence stage
evidence still limited

case report or case series

Hexahydrocannabinol-induced rhabdomyolysis and acute kidney injury: a case report combining comprehensive toxicokinetic and metabolomic investigations.

On this page, this source examines HHC and safety, risk, adverse-event, or formulation-specific concerns. 2

Study type
case report or case series
Population or model
people or patients
Outcome focus
safety, risk, adverse-event, or formulation-specific concerns
Evidence stage
mechanism-focused research

case report or case series

[Not Available].

On this page, this source examines HHC and safety, risk, adverse-event, or formulation-specific concerns. 3

Study type
case report or case series
Outcome focus
safety, risk, adverse-event, or formulation-specific concerns
Evidence stage
human research

human research

Derivation of a health-based guidance value for Δ8-tetrahydrocannabinol (Δ8-THC) and its occurrence in food.

On this page, this source examines THC and safety, risk, adverse-event, or formulation-specific concerns. 4

Population or model
people or patients
Outcome focus
safety, risk, adverse-event, or formulation-specific concerns
Evidence stage
human research

human research

Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis.

On this page, this source examines Delta-8 THC and safety, risk, adverse-event, or formulation-specific concerns. 5

Population or model
people or patients
Outcome focus
safety, risk, adverse-event, or formulation-specific concerns
Evidence stage
human research

Safety and limits

What should readers keep in mind?

Research on Delta-10 THC should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What is Delta-10 THC?

Delta-10 THC is a cannabinoid-related compound studied across Safety, risk, adverse events, and formulation concerns. This page separates those research questions so they are not mistaken for one broad claim. 7

What has Delta-10 THC been studied for?

The current source set includes Safety, risk, adverse events, and formulation concerns. Each area may use different doses, products, routes, populations, and outcome measures. 8

How strong is the research on Delta-10 THC?

The source set includes human research as well as earlier-stage studies. 9

Is Delta-10 THC safe?

Safety cannot be answered for Delta-10 THC without context. Dose, route, formulation, medications, and the person using it can all change risk. 10

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America's Poison Centers. evidence still limited PubMed 38686923 DOI 10.1080/15563650.2024.2340115
  2. 2
    Hexahydrocannabinol-induced rhabdomyolysis and acute kidney injury: a case report combining comprehensive toxicokinetic and metabolomic investigations. case report or case series; mechanism-focused research PubMed 42106886 DOI 10.1186/s42238-026-00435-7
  3. 3
    [Not Available]. case report or case series; human research PubMed 39323250 DOI 10.61409/v04240241
  4. 4
    Derivation of a health-based guidance value for Δ8-tetrahydrocannabinol (Δ8-THC) and its occurrence in food. human research PubMed 41262681 DOI 10.2903/j.efsa.2025.9735
  5. 5
    Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis. human research PubMed 38127427 DOI 10.2196/49469
  6. 6
    [Not all drugs are the same]. narrative or expert review; evidence still limited PubMed 23974649 DOI 10.1007/s00063-013-0219-1
  7. 7
    Cannabimimetic and discriminative stimulus effects of hexahydrocannabinols in mice. animal study; preclinical research PubMed 40176500 DOI 10.1177/02698811251330739
  8. 8
    Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats. animal study; preclinical research PubMed 40643195 DOI 10.1093/ijnp/pyaf041
  9. 9
    A Survey Study of Individuals Using Hexahydrocannabinol Cannabis Products: Use Patterns and Perceived Effects. evidence still limited PubMed 37934167 DOI 10.1089/can.2023.0143
  10. 10
    Brands of Intoxicating Cannabis Products in Vape Shops: United States, 2023. evidence still limited PubMed 41324909 DOI 10.1080/10826084.2025.2592227
  11. 11
    Delta-8 THC Retail Availability, Price, and Minimum Purchase Age. evidence still limited PubMed 36342930 DOI 10.1089/can.2022.0079
  12. 12
    Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. case report or case series; evidence still limited PubMed 36742440 DOI 10.2147/dhps.s391857
See all 12 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Hexahydrocannabinol-induced rhabdomyolysis and acute kidney injury: a case report combining comprehensive toxicokinetic and metabolomic investigations. case report or case series; mechanism-focused research / 1 linked research note PubMed 42106886
  2. [Not all drugs are the same]. narrative or expert review; evidence still limited / 1 linked research note PubMed 23974649
  3. Brands of Intoxicating Cannabis Products in Vape Shops: United States, 2023. evidence still limited / 1 linked research note PubMed 41324909
  4. Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. case report or case series; evidence still limited / 1 linked research note PubMed 36742440
  5. Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America's Poison Centers. evidence still limited / 1 linked research note PubMed 38686923
  6. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis. human research / 1 linked research note PubMed 38127427
  7. Derivation of a health-based guidance value for Δ8-tetrahydrocannabinol (Δ8-THC) and its occurrence in food. human research / 1 linked research note PubMed 41262681
  8. Delta-8 THC Retail Availability, Price, and Minimum Purchase Age. evidence still limited / 1 linked research note PubMed 36342930
  9. Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats. animal study; preclinical research / 1 linked research note PubMed 40643195
  10. [Not Available]. case report or case series; human research / 1 linked research note PubMed 39323250
  11. A Survey Study of Individuals Using Hexahydrocannabinol Cannabis Products: Use Patterns and Perceived Effects. evidence still limited / 1 linked research note PubMed 37934167
  12. Cannabimimetic and discriminative stimulus effects of hexahydrocannabinols in mice. animal study; preclinical research / 1 linked research note PubMed 40176500